## **Core Concept**
Buprenorphine is a medication used to treat opioid use disorder and chronic pain. It belongs to a specific class of opioids that have a unique pharmacological profile. Understanding its classification is crucial for managing patients and understanding its mechanism of action.

## **Why the Correct Answer is Right**
Buprenorphine is classified as a **partial opioid agonist**. This means it activates opioid receptors, but to a lesser extent than full agonists like morphine. Its partial agonist activity at the mu-opioid receptor contributes to its therapeutic effects, including analgesia and reduction of opioid withdrawal symptoms, with a lower risk of overdose and respiratory depression compared to full agonists.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because buprenorphine does not fit the description of a full opioid agonist; it does not activate opioid receptors to the same extent as drugs like morphine.
- **Option B:** This option is incorrect as buprenorphine is not classified merely as an opioid; its specific pharmacological properties as a partial agonist make it more accurately described with greater specificity.
- **Option D:** This option is incorrect because buprenorphine is not an opioid antagonist; it does have agonist activity, although partial.

## **Clinical Pearl / High-Yield Fact**
A key point to remember about buprenorphine is its use in ** Medication-Assisted Treatment (MAT) for opioid use disorder**. It helps reduce cravings and withdrawal symptoms, making it easier for patients to maintain sobriety. Its partial agonist properties make it a safer alternative to full opioid agonists.

## **Correct Answer:** C. Partial agonist.